Oculis Holding AG (OCS)
NASDAQ: OCS · IEX Real-Time Price · USD
11.98
+0.01 (0.08%)
Apr 24, 2024, 4:30 PM EDT - Market closed

Oculis Holding AG Market Cap

Oculis Holding AG has a market cap or net worth of $439.06 million as of April 25, 2024. Its market cap has increased by 23.06% in one year.

Market Cap
439.06M
Enterprise Value
339.34M
1-Year Change
23.06%
Ranking
Category
Stock Price
$11.98

Market Cap Chart

Since March 16, 2021, Oculis Holding AG's market cap has increased from $129.00M to $439.06M, an increase of 240.36%. That is a compound annual growth rate of 48.27%.

History

DateMarket Cap% Change
Apr 24, 2024439.10M0.09%
Apr 23, 2024438.70M0.16%
Apr 22, 2024438.00M1.46%
Apr 19, 2024431.70M-
Apr 18, 2024431.70M-1.01%
Apr 17, 2024436.10M-0.84%
Apr 16, 2024439.80M-0.25%
Apr 15, 2024440.90M0.64%
Apr 12, 2024438.10M-0.30%
Apr 11, 2024439.40M2.64%
Apr 10, 2024428.10M6.20%
Apr 9, 2024403.10M2.21%
Apr 8, 2024394.40M-3.57%
Apr 5, 2024409.00M0.10%
Apr 4, 2024408.60M3.13%
Apr 3, 2024396.20M-1.81%
Apr 2, 2024403.50M-5.26%
Apr 1, 2024425.90M-3.56%
Mar 28, 2024441.60M1.17%
Mar 27, 2024436.50M2.59%
Mar 26, 2024425.50M-0.77%
Mar 25, 2024428.80M-0.26%
Mar 22, 2024429.90M0.94%
Mar 21, 2024425.90M-2.09%
Mar 20, 2024435.00M0.25%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Acelyrin 447.76M
LifeMD 447.26M
Taysha Gene Therapies 445.10M
Third Harmonic Bio 445.01M
Theravance Biopharma 441.19M
Editas Medicine 440.78M
Entrada Therapeutics 428.41M
Avid Bioservices 427.81M
Market Cap Rankings